Home / Import refusals / 1FX-3824380-4/10002/1

FDA Import Refusal 1FX-3824380-4/10002/1 — Intas Pharmaceuticals Ltd

Intas Pharmaceuticals Ltd — FEI 3013501434

The FDA refused shipment 1FX-3824380-4/10002/1 from Intas Pharmaceuticals Ltd (India) on July 10, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
July 10, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PCB73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-9375889-2/30003/1 (Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1919971-7/50003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9186485-8/190003/1 (Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9094971-3/30003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9094971-3/10003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources